Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Astellas Pharma : Transfer of Distribution Rights for Targocid® and Maalox®

09/08/2011 | 10:10pm US/Eastern

Astellas Pharma Inc. (“Astellas Pharma”; Headquarters: Chuo-ku, Tokyo; President and CEO: Yoshihiko Hatanaka) and sanofi-aventis K.K. (“sanofi-aventis”; Headquarters: Shinjuku-ku, Tokyo; Representative Director and President: Jez Moulding) announced that Astellas Pharma will transfer the rights to distribute the injectable antibiotics Targocid® (generic name: teicoplanin) and the treatment for peptic ulcer and gastritis Maalox® (generic name: dried aluminum hydroxide gel and magnesium hydroxide) to sanofi-aventis effective on January 1, 2012. This transfer of distribution rights is taking place based on the expiration of the contract.

<Products for which distribution rights will be transferred>

React to this article
Latest news on ASTELLAS PHARMA INC
02/04 ASTELLAS PHARMA : Journal of Clinical Oncology Publishes Results from the STRIVE..
02/01 ASTELLAS PHARMA : Manchester Metropolitan University -University to analyse Big ..
02/01 ASTELLAS PHARMA : Announces Acquisition of Own Shares (Under the provision of it..
01/31 ASTELLAS PHARMA : and CLINO Announce License Agreement to Develop and Commercial..
01/28 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 139KB)
01/27 ASTELLAS PHARMA : Extends Tender Offer to Acquire All Outstanding Shares of Ocat..
01/27 ASTELLAS PHARMA : 'Help us to help you': A survey of UK doctors gives 'greater p..
01/25 ASTELLAS PHARMA : Extends Tender Offer to Acquire All Outstanding Shares of Ocat..
01/22 ASTELLAS PHARMA : Extends Tender Offer to Acquire All Outstanding Shares of Ocat..
01/22 ASTELLAS PHARMA : REPATHA® (EVOLOCUMAB) APPROVED AS FIRST PCSK9 INHIBITOR IN JAP..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials